Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects

Takuji Torimura, Hideki Iwamoto

Clin Mol Hepatol. 2021;27(2):236-245. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0204

View: 8062 Download: 372 Web of Science: 40 Crossref: 38

Ultraselective conventional transarterial chemoembolization: When and how?

Shiro Miyayama

Clin Mol Hepatol. 2019;25(4):344-353. Published online April 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0016

View: 10987 Download: 548 Web of Science: 28 Crossref: 31

3

Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm

Min Jae Yang, M.D., So Yun An, M.D., Eun Joon Moon, M.D., Min Suk Lee, M.D., Joo An Hwang, M.D., Jae Youn Cheong, M.D., Je Hwan Won, M.D. Jai Keun Kim, M.D. Hee Jung Wang, M.D. Sung Won Cho, M.D.

Clin Mol Hepatol. 2009;15(4):474-485. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.474

View: 5252 Download: 44 Crossref: 4

4

A Case of Infiltrative Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis Successfully Treated by Transarterial Chemoembolization

Sun-Jung Myung, M.D., Jung-Hwan Yoon, M.D., Geum-Youn Gwak, M.D., Cheol Min Shin, M.D., Dong Won Ahn, M.D., Su Jong Yu, M.D., Ji-Won Yu, M.D., Soo-Jeong Cho, M.D., Jin Wook Chung, M.D. and Hyo-Suk Lee, M.D.

Clin Mol Hepatol. 2006;12(1):107-111. Published online January 1, 1970

View: 2887 Download: 22

3

Clinical Features of Liver Abscess Developed after Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma

Min Hyung Kim, M.D., Moon Seok Choi, M.D., Yong Sung Choi, M.D., Do Young Kim, M.D., Ji Min Lee, M.D. Seung Woon Paik, M.D., Joon Hyuek Lee, Kwang Cheol Koh, M.D., Byung Cheol Yoo, M.D., Dongil Choi, M.D. and Jong Chul Rhee

Clin Mol Hepatol. 2006;12(1):55-64. Published online January 1, 1970

View: 3324 Download: 42

1 |

Viewed By 5164	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5021	MAFLD: How is it different from NAFLD?
Viewed By 4930	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3643	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3594	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search